GlassScriptPhysician profile
Amanda R Dailey
NPI 1588026728
$536.29
in general payments reported to CMS, 2019-2025
16 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $201 · 2021: $54.54 · 2022: $99.34 · 2024: $40.07 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $181.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $90.00 | 2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $67.19 | 2020-2021 | |
| Lilly USA, LLC | $47.77 | 2020 | |
| Abbott Laboratories | $40.42 | 2022 | |
| Recor Medical INC | $40.07 | 2024 | Paradise Renal Denervation System |
| Astrazeneca Pharmaceuticals LP | $38.55 | 2020 | |
| Ferring Pharmaceuticals INC. | $33.31 | 2021-2022 | |
| Novo Nordisk INC | $32.62 | 2020 | |
| Dynavax Technologies Corporation | $28.97 | 2025 | Heplisav-B |
| Sanofi-Aventis U.S. LLC | $21.99 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.75 | 2022 | |
| Boston Scientific Corporation | $17.54 | 2021 | |
| Esperion Therapeutics, INC. | $16.15 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.60 | 2020 | |
| Amgen INC. | $13.89 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $12.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Dailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.